Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Medtronic (MDT) -- Ignore unavailable to you. Want to Upgrade?

To: Dennis who wrote (317)	7/14/1998 12:59:00 PM
From: Ernie Kelley	Read Replies (1) \| Respond to of 687

Dr. Marshall Stanton, of Mayo Medical School, to Join Medtronic Cardiac Rhythm Management MINNEAPOLIS, July 14 /PRNewswire/ -- Medtronic, Inc. (NYSE: MDT - news), today announced the appointment of Marshall S. Stanton, M.D., as Vice President, Medical Affairs, for its Cardiac Rhythm Management organizations. Dr. Stanton, now a cardiologist and electrophysiologist on the faculty of the Mayo Graduate School of Medicine in Rochester, Minn., will join Medtronic on September 23, 1998. In his new role, Dr. Stanton will work with Medtronic scientists, education and marketing specialists as they develop and introduce to physicians such implantable devices as new pacemakers and defibrillators as well as ablation and mapping systems for treatment of hearts that beat too fast or too slowly. ''We feel extremely fortunate to add the capabilities and expertise of Marshall Stanton as we implement our global cardiac rhythm management strategy,'' said Stephen H. Mahle, President, Medtronic Cardiac Rhythm Management. ''His extensive background in clinical practice, education, and research in cardiovascular medicine will be invaluable as we develop and offer technologies to treat complex diseases that now tax the resources of healthcare systems worldwide.'' Dr. Stanton is a 1978 graduate of the University of Pennsylvania and received his medical doctorate from the Medical College of Virginia in 1982. He completed a residency in internal medicine at the Mayo Medical School in 1985 and a fellowship in cardiology at the Indiana University School of Medicine in 1988. Dr. Stanton joined the faculty at Mayo as Assistant Professor of Medicine and Director of Education for Electrophysiology in 1989 and subsequently was promoted to Associate Professor and Director of the Cardiovascular Training Program. He is a fellow of the American College of Cardiology, serving on its Electrocardiology Committee, and of the American Heart Association's Council on Clinical Cardiology. He also is chairman of the Fellowship Committee of the North American Society of Pacing and Electrophysiology and serves on its Committee on Health Policy. Medtronic, Inc., headquartered in Minneapolis, is the world's leading medical technology company specializing in implantable and interventional therapies. biz.yahoo.com Getting good inside talent is always great for a medical company. Dr's respect other Dr's, this is a plus IMHO. - Ernie -